Skip to main content
. 2020 Nov 2;12:11015–11029. doi: 10.2147/CMAR.S272797

Table 2.

Univariable Analysis in Elderly Patients with iCCA by Using Competing Risk Model in the Training Set

Variables Gray’s Test P-value Cumulative Incidence Function
12-mo 36-mo 60-mo
Age 0.119 0.729
 ≥70years 0.229 0.477 0.517
 <70years 0.174 0.421 0.522
Sex 1.665 0.197
 Male 0.201 0.460 0.583
 Female 0.163 0.391 0.425
Child-pugh score 0.745 0.388
 B 0.250 0.250 0.594
 A 0.180 0.444 0.525
HbsAg 0.224 0.636
 Positive 0.212 0.418 0.529
 Negative 0.171 0.436 0.518
Portal hypertension 2.649 0.104
 Present 0.136 0.318 0.415
 Absent 0.230 0.460 0.546
CA19-9 level 6.672 0.010
 >79 U/mL 0.247 0.524 0.569
 ≤79 U/mL 0.128 0.346 0.477
Maximum tumor size 5.653 0.017
 >5cm 0.243 0.508 0.609
 ≤5cm 0.121 0.344 0.412
Tumor number 4.721 0.030
 Multiple 0.310 0.552 0.581
 Single 0.128 0.378 0.493
Tumor encapsulation 1.575 0.209
 Incomplete 0.202 0.508 0.547
 Complete 0.167 0.348 0.489
MVI 19.429 <0.001
 Yes 0.357 0.724 0.775
 No 0.146 0.365 0.463
Macroscopic vascular invasion 35.591 <0.001
 Yes 0.358 0.679 0.761
 No 0.113 0.323 0.412
Satellite nodules 4.260 0.039
 Yes 0.232 0.622 0.811
 No 0.178 0.407 0.487
Lymph node metastasis 7.687 <0.001
 Yes 0.306 0.662 0.683
 No 0.149 0.363 0.472
Extent of liver resection 0.243 0.622
 Major 0.226 0.442 0.529
 Minor 0.140 0.421 0.512
Operation approach 0.594 0.441
 LLR 0.222 0.575 0.575
 OLR 0.182 0.421 0.514

Note: Bold indicates statistically significant difference.

Abbreviations: HBsAg, hepatitis B surface antigen; CA19-9, carbohydrate antigen 19–9; MVI, microvascular invasion; LLR, laparoscopic liver resection; OLR, open liver resection.